FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

85 letters match. Newest first.

  1. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  2. Beaute Bounty

    FDA warns Beaute Bounty that its stem cell and placenta products are unapproved drugs and unlicensed biologics.

    High risk
  3. Tides Medical LLC

    FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.

    High risk
  4. NexCell Scientific Inc

    NexCell Scientific markets an unapproved, unlicensed umbilical cord blood cell product with serious manufacturing violations.

    High risk
  5. Stephen J. Fallon, Ph.D.

    FDA warns clinical investigator Stephen J. Fallon, Ph.D. over consent and record failures in an HIV self-test study.

    High risk
  6. R3 Medical Companies

    FDA cites R3 Medical affiliates for selling unapproved umbilical cord and exosome biologics without licenses and with serious manufacturing violations.

    High risk
  7. Genzyme Ireland Limited

    Genzyme Ireland's Waterford biologics plant cited for quality unit and data integrity failures across two licensed products.

    High risk
  8. Blue Horizon International, LLC

    FDA warned Blue Horizon International over unapproved stem cell and exosome biologics marketed for serious diseases without a license.

    High risk
  9. Adnan Dahdul, MD

    FDA warns clinical investigator Dr. Adnan Dahdul over consent, eligibility and record failures in a biologics study.

    High risk
  10. Estar Technologies Ltd

    FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.

    High risk
  11. 4U Health

    FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.

    High risk
  12. Dynamic Stem Cell Therapy

    FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.

    High risk
  13. ProDx Health

    FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.

    High risk
  14. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  15. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  16. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  17. Germaphobix

    FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.

    High risk
  18. Genetrace

    FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.

    High risk
  19. Genovate

    FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.

    High risk
  20. Green Valley Fertility Partners

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  21. Microvascular Tissue, Inc.

    CGMP/Deviations/Biologics License Application (BLA)

  22. Celularity, Inc

    Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)

  23. BioXtek LLC

    Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)

  24. Lux Therapeutics LLC dba Ponya Therapeutics LLC

    Unapproved New Drug/Unlicensed Biological Product/Biologics License Application (BLA)

  25. Allovate Therapeutics, LLC

    CGMP/Deviations/Biologics License Application (BLA)

  26. New Life Medical Services, LLC

    CGMP/Deviations/Biologics License Application (BLA)

  27. Cellebration LLC

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  28. CSL Behring

    Advertising & Promotional Labeling/Drugs/Biological Products

  29. NuVida Medical LLC

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  30. Platinum Biologics LLC

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  31. Innate Healthcare Institute

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  32. O3UV, LLC

    Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device

  33. InVia Fertility Specialists, PLLC

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  34. Amy Lightner, MD

    Bioresearch Monitoring Program

  35. Supreme Rejuvenation, LLC

    Unapproved New Drugs/Misbranded

  36. Skye Biologics Holdings LLC

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  37. MG Infusions

    CGMP/Deviations/Biologics License Application (BLA)

  38. Sperm Bank, Inc. dba Fertility Center of California

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  39. BioStem Life Sciences

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  40. Chara Biologics, Inc.

    CGMP/Deviations/Biologics License Application (BLA)

  41. Evolutionary Biologics Inc.

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  42. XO Biologix, LLC

    Unapproved New Drugs/Adulterated

  43. Frontier Biologics, LLC

    Unapproved New Drug/Unlicensed Biological Product Violations

  44. Blackfly Investments, LLC dba Molecular® Testing Labs

    Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)

  45. Namita A. Goyal, M.D.

    Clinical Investigator

  46. Pinnacle Transplant Technologies, LLC

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  47. Amnio Technology, LLC

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  48. Hemarus LLC

    CGMP/Blood & Blood Components/Adulterated

  49. Mother Stem Institute, Corp.

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  50. Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.

    Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)